Hypothesis

Chronic exposure to low‑grade microbial‑associated molecular patterns (MAMPs) in the aging intestine shifts the Nrf2‑mediated hormetic set point leftward, converting a protective stress‑response into a maladaptive, NADPH‑draining state that fuels intestinal barrier leak and systemic inflammaging.

Mechanistic rationale

1. Threshold lowering – Age‑dependent epigenetic remodeling (e.g., increased H3K27ac at antioxidant response elements) reduces the amount of stress needed to keep Nrf2 nuclear, as shown by constitutive low‑level Nrf2 target expression in aged enteroendocrine cells (see [4]).
2. Resource drain – Persistent Nrf2 activity drives continuous transcription of GSH‑synthetic enzymes (GCLM, GSS) and NADPH‑producing enzymes (G6PD). Because the stimulus never reaches the hormetic peak, these pathways operate far below Vmax but chronically consume NADPH and cysteine, depleting the pool needed for acute ROS bursts (see [1] for GSH dynamics).
3. Failed inducible reserve – When a secondary hit (e.g., dietary fat, pathogen) occurs, the already‑engaged Nrf2 system cannot further up‑regulate, leaving the cell with a blunted adaptive capacity and a shift toward NF‑κB‑mediated inflammation (see [3]).

Testable predictions

• Prediction 1: Aged mice will show elevated basal Nrf2 target mRNA (Nqo1, Ho‑1) but a reduced fold‑induction after an acute sulforaphane challenge compared with young mice.
• Prediction 2: Inhibiting Nrf2 specifically in aged enteroendocrine cells (using Villin‑CreER; Nrf2^fl/fl + tamoxifen) will normalize the inducible response, restore GSH/GSSG ratio after challenge, and decrease intestinal permeability (FITC‑dextran assay).
• Prediction 3: These mice will exhibit lower serum LPS‑binding protein and improved glucose tolerance, linking gut‑derived hormetic exhaustion to systemic metabolic health.

Experimental outline

| Group | Age | Genotype | Intervention | Readouts (48 h post‑challenge) |-------|-----|----------|--------------|--------------------------------- | 1 | Young (3 mo) | WT | Vehicle | Basal & induced Nrf2 targets, GSH/GSSG, FITC‑dextran | 2 | Aged (24 mo) | WT | Vehicle | Same as above | 3 | Aged (24 mo) | Villin‑CreER; Nrf2^fl/fl | Tamoxifen (Nr‑f2 KO) | Same as above | 4 | Aged (24 mo) | WT | Sulforaphane (5 mg/kg) | Inducible response magnitude | 5 | Aged (24 mo) | Villin‑CreER; Nrf2^fl/fl | Tamoxifen + Sulforaphane | Test whether KO rescues inducibility

Expected outcome: Groups 2 and 4 show high basal Nrf2 activity but low inducibility and GSH depletion; Group 3 and 5 show restored inducibility, higher GSH/GSSG, and reduced permeability.

Falsifiability

If aged enteroendocrine cells do not display constitutively elevated Nrf2 targets, or if Nrf2 deletion fails to improve barrier function or metabolic readouts, the hypothesis that chronic low‑grade MAMP exposure lowers the Nrf2 hormetic set point and drives maladaptive NADPH drain would be refuted.

Broader implication

This framework reframes hormesis not as a universal longevity trigger but as a stress‑sensing rheostat whose maladaptive tuning in aged tissues converts a protective circuit into a source of metabolic inflammation, offering a precise point of intervention (e.g., transient Nrf2 modulators) to restore hormetic fidelity.